Anti-obesity Pharmacotherapy and Inflammation

NCT05756764 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Semaglutide
DRUG: Phentermine-Topiramate combination
DRUG: Phentermine
DRUG: Tirzepatide
DRUG: Topiramate
DRUG: Diethylpropion
DRUG: Naltrexone/Bupropion
DRUG: Liraglutide

Sponsor

Louisiana State University Health Sciences Center in New Orleans

Collaborators

[object Object]
[object Object]
[object Object]